CE-224,535
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for CE-224,535, covering 2009-06-09 to 2022-04-04. Get the full timeline:
Most recent: Clinical Trial Update: Study of CE-224,535 A Twice Daily Pill To Control Rheumatoid Arthritis In Patients Who Have Not Totally Improved With Methotrexate [Phase 2]